Generic semaglutide and tirzepatide, often accessed through compounding pharmacies, offer a disruptive alternative to high-cost brand names. While legacy pharmaceutical models prioritize profit, the generic route ensures that life-saving metabolic tools remain accessible to those without premium insurance coverage. Scientific efficacy remains the priority over corporate branding.
Notice: The contributors to Her Metabolic Health are researchers and advocates, not licensed medical professionals. Content is for informational purposes only. Always consult your physician before beginning or altering any medication or protocol.
